Bosh sahifaPEB • NZE
add
Pacific Edge Ltd
Yopilish kursi
0,14 $
Kunlik diapazon
0,14 $ - 0,14 $
Yillik diapazon
0,071 $ - 0,19 $
Bozor kapitalizatsiyasi
113,67 mln NZD
Oʻrtacha hajm
192,85 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NZE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(NZD) | mar, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 5,64 mln | -2,51% |
Joriy xarajat | 10,69 mln | -11,05% |
Sof foyda | -7,14 mln | 12,88% |
Sof foyda marjasi | -126,68 | 10,64% |
Har bir ulushga tushum | — | — |
EBITDA | -7,75 mln | 9,33% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
(NZD) | mar, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 50,26 mln | -35,39% |
Jami aktivlari | 65,45 mln | -28,01% |
Jami passivlari | 10,83 mln | 32,83% |
Umumiy kapital | 54,62 mln | — |
Tarqatilgan aksiyalar | 811,27 mln | — |
Narxi/balansdagi bahosi | 2,03 | — |
Aktivlardan daromad | -30,03% | — |
Kapitaldan daromad | -33,48% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(NZD) | mar, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | -7,14 mln | 12,88% |
Operatsiyalardan naqd pul | -5,38 mln | 7,28% |
Sarmoyadan naqd pul | 10,06 mln | 123,79% |
Moliyadan naqd pul | -199,50 ming | 59,90% |
Naqd pulning sof oʻzgarishi | 4,40 mln | 284,71% |
Boʻsh pul | -4,15 mln | 22,62% |
Haqida
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the New Zealand NZX main board stock exchange and is included in the NZX 50 Index. Wikipedia
Tashkil etilgan
2001
Xodimlar soni
114